Dr. Issam E. Cheikh, MD

Dr. Cheikh practices at 33rd Street Surgery Center LLC in Baltimore, Maryland.

Dr. Cheikh's NPI, 1639132848, was assigned on April 10, 2006. Dr. Cheikh graduated from Damascus University Faculty of Medicine in 1968. Dr. Cheikh holds Maryland license D0014748.

Dr. Cheikh's primary practice is 33rd Street Surgery Center LLC, at 200 E 33rd St, Baltimore, MD 21218 in Baltimore City. The practice phone is (410) 554-4455.

Dr. Cheikh's primary practice is 33rd Street Surgery Center LLC in Baltimore, Maryland. Dr. Cheikh is also affiliated with MedStar Good Samaritan Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Cheikh to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cheikh practices, 4 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Cheikh's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Cheikh is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dr. Cheikh is licensed in Maryland.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, fluid and electrolyte imbalances, high cholesterol, obesity, osteoporosis and overactive thyroid among the conditions Dr. Cheikh treats.

CMS data shows 974 Medicare services from Dr. Cheikh across 7 procedure codes in 2024, for 246 Medicare patients. Medicare paid $72,124 for them.

CMS counts 246 Medicare patients who saw Dr. Cheikh in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cheikh's median patient age at 72, with 62% women.

In 2024, Dr. Cheikh wrote 1,839 Medicare Part D claims for 159 patients. 58% of them were for generic drugs. CMS names the drug for 1,467 of them, across 41 drugs with 11 or more claims each, at $574,957 in total drug cost. In 2023, CMS named 1,231 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Cheikh for performance year 2024, reported as part of a group. Dr. Cheikh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cheikh as offering telehealth.

Dmand AI links 6 papers to Dr. Cheikh in 2012. 2012 was the busiest year, with 3. Dr. Cheikh has published most often in J Community Hosp Intern Med Perspect.

CMS Open Payments shows 59 general payments to Dr. Cheikh from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Novo Nordisk Inc paid the most, $237.

Dmand AI lists 4 awards for Dr. Cheikh, most recently AACE Fellow in 2012.

Dr. Cheikh graduated from Damascus University Faculty of Medicine in 1968. Dr. Cheikh is a member of ACP and ENDO.

Dr. Cheikh is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.